EGM
ANIK icon

Engineers Gate Manager’s Anika Therapeutics ANIK Stock Holding History

Engineers Gate Manager’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Sell
22,990
-35,838
-61% -$531K ﹤0.01% 1717
2026
Q1 		$853K Buy
58,828
+18,552
+46% +$215K 0.01% 1133
2025
Q4 		$387K Buy
40,276
+16,150
+67% +$155K ﹤0.01% 1494
2025
Q3 		$227K Buy
24,126
+7,658
+47% +$73.1K ﹤0.01% 1853
2025
Q2 		$174K Sell
16,468
-6,011
-27% -$75.8K ﹤0.01% 1921
2025
Q1 		$338K Sell
22,479
-9,474
-30% -$158K 0.01% 1646
2024
Q4 		$526K Buy
31,953
+18,065
+130% +$356K 0.01% 1383
2024
Q3 		$343K Sell
13,888
-7,887
-36% -$204K 0.01% 1566
2024
Q2 		$552K Sell
21,775
-6,123
-22% -$159K 0.01% 1176
2024
Q1 		$709K Buy
27,898
+814
+3% +$19.7K 0.02% 1017
2023
Q4 		$614K Buy
27,084
+2,562
+10% +$53K 0.02% 1069
2023
Q3 		$457K Buy
+24,522
New +$509K 0.02% 1097
2022
Q3 		– Sell
-25,816
Closed -$576K – 1592
2022
Q2 		$576K Buy
+25,816
New +$576K 0.02% 1036
2021
Q3 		– Sell
-12,531
Closed -$542K – 1616
2021
Q2 		$542K Sell
12,531
-6,139
-33% -$261K 0.03% 785
2021
Q1 		$762K Buy
18,670
+3,660
+24% +$139K 0.04% 723
2020
Q4 		$679K Sell
15,010
-2,486
-14% -$94.3K 0.03% 790
2020
Q3 		$619K Sell
17,496
-3,910
-18% -$141K 0.03% 869
2020
Q2 		$808K Buy
21,406
+1,231
+6% +$40.6K 0.04% 696
2020
Q1 		$583K Buy
20,175
+13,339
+195% +$540K 0.04% 683
2019
Q4 		$354K Sell
6,836
-5,646
-45% -$328K 0.02% 1173
2019
Q3 		$685K Sell
12,482
-8,010
-39% -$411K 0.03% 665
2019
Q2 		$832K Sell
20,492
-8,931
-30% -$326K 0.05% 569
2019
Q1 		$890K Buy
+29,423
New +$1.01M 0.05% 474
2018
Q3 		– Sell
-23,972
Closed -$767K – 896
2018
Q2 		$767K Buy
+23,972
New +$987K 0.06% 431

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Engineers Gate Manager's ANIK Position: Q2 2026 in Review

Engineers Gate Manager reduced its Anika Therapeutics (ANIK) stake by 61% in Q2 2026, selling an estimated $531K and leaving 22,990 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #1717.

Engineers Gate Manager first reported a position in ANIK in Q2 2018 and has held it in 24 quarters since. The position peaked at $890K in Q1 2019. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Engineers Gate Manager held 22,990 shares of Anika Therapeutics worth $336K as of Q2 2026.
  • Engineers Gate Manager sold 35,838 Anika Therapeutics shares in Q2 2026, an estimated $531K.
  • Anika Therapeutics made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1717 holding.
  • Engineers Gate Manager first reported a position in Anika Therapeutics in Q2 2018 and has held it in 24 quarters since.
  • Engineers Gate Manager's Anika Therapeutics position peaked at $890K in Q1 2019.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.